Cargando…

Variability in Private Payer Medical Policies for Osteochondral Allograft Transplantation Demonstrates the Absence of Standardization in Medical Criteria Between Payers

PURPOSE: To define the criteria for coverage for a cartilage restoration procedure and osteochondral allograft (OCA) transplantation and to investigate coverage for OCA procedures among private payer medical policies. METHODS: A systematic search of private payer websites was conducted to identify p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tabbaa, Suzanne M., Crawford, Dennis C., Provencher, Matthew, Farr, Jack, Bugbee, Willliam D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Systematic Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791874/ https://www.ncbi.nlm.nih.gov/pubmed/36579033 http://dx.doi.org/10.1016/j.asmr.2022.09.005

Ejemplares similares

A Private Payer Persective
por: Shurney, Dexter W.
Publicado: (2006)

Patient and Payer Preferences for Additional Value Criteria
por: Jakab, Ivett, et al.
Publicado: (2021)

Variation in Private Payer Coverage of Rheumatoid Arthritis Drugs
por: Chambers, James D., et al.
Publicado: (2016)

Private Payer Coverage Policies for ApoE-e4 Genetic Testing
por: Arias, Jalayne J., et al.
Publicado: (2021)

How do Medicare Physician Fees Compare With Private Payers?
por: Miller, Mark E., et al.
Publicado: (1993)

Metrics of OsteoChondral Allografts (MOCA) Group Consensus Statements on the Use of Viable Osteochondral Allograft
por: Görtz, Simon, et al.
Publicado: (2021)

Hospitals and the Tax-Payer
Publicado: (1920)

Actuarial Analysis of Private Payer Administrative Claims Data for Women With Endometriosis
por: Mirkin, David, et al.
Publicado: (2007)

Specialty Pharmacy Cost Management Strategies of Private Health Care Payers
por: Stern, Debbi, et al.
Publicado: (2006)

Patients’ and Caregivers’ Experiences with the Multi-Payer Advanced Primary Care Practice Demonstration
por: Wilson, Ellen K., et al.
Publicado: (2020)

Comment on: “Cost-Utility Analysis of Duloxetine in Osteoarthritis: A US Private Payer Perspective”
por: Liedgens, Hiltrud, et al.
Publicado: (2013)

US public and private payer coverage for tobacco cessation treatments and barriers to accessing treatments
por: Hussain, Radha, et al.
Publicado: (2022)

All-payer ratesetting: Down but not out
por: Anderson, Gerard F.
Publicado: (1992)

Are payers treating orphan drugs differently?
por: Cohen, Joshua P., et al.
Publicado: (2014)

Payer-Negotiated Prices for Telemedicine Services
por: Wu, Shannon S., et al.
Publicado: (2022)

An integrated valuation model for payer and investor
por: Nuijten, Mark, et al.
Publicado: (2022)

Payer Perspectives on Health Technology Assessment
por: Watkins, John B.
Publicado: (2012)

The impact of payer status on hospital admissions: evidence from an academic medical center
por: Zhao, Yanying, et al.
Publicado: (2021)

Which Variables Predict Osteochondral Allograft Failure?
por: Bugbee, William
Publicado: (2020)

Payer Policy Behavior Towards Opioid Pharmacotherapy Treatment in Ohio
por: Molfenter, Todd, et al.
Publicado: (2018)

Fresh Osteochondral Allograft Transplantation for Osteochondritis Dissecans of the Knee
por: Sadr, Kamran N., et al.
Publicado: (2014)

Disparity in clinical outcomes after cardiac surgery between private and public (NHS) payers in England
por: Benedetto, Umberto, et al.
Publicado: (2020)

Financial Burden of Discarded Weight-based Antineoplastic Drugs to Payers and Patients in the Private Insurance Market
por: Shih, Ya-Chen Tina, et al.
Publicado: (2021)

Application of Economic Analyses in U.S. Managed Care Formulary Decisions: A Private Payer's Experience
por: Watkins, John B., et al.
Publicado: (2006)

Assessing payer perspectives on health information exchange
por: Cross, Dori A, et al.
Publicado: (2016)

Pharmaceutical Technology Assessment: Perspectives from Payers
por: Leung, Musetta Y., et al.
Publicado: (2012)

Trends in Shoulder Stabilization Techniques Used in the United States Based on a Large Private-Payer Database
por: Riff, Andrew J., et al.
Publicado: (2017)

Private Payer Coverage Policies for Whole Exome Sequencing (WES) in Pediatric Patients: Trends Over Time and Analysis of Evidence Cited
por: Douglas, Michael P., et al.
Publicado: (2018)

Le CERN peine à payer son accélérateur
Publicado: (2006)

Use of Diagnosis-Related Groups by Non-Medicare Payers
por: Carter, Grace M., et al.
Publicado: (1994)

Geographic variation in cesarean delivery in the United States by payer
por: Henke, Rachel Mosher, et al.
Publicado: (2014)

Commentary on “Health Spending Under Single-Payer Approaches”
por: Ginsburg, Paul B.
Publicado: (2020)

The Effect of Payer Status on Survival of Patients With Prostate Cancer
por: Suh, Winston, et al.
Publicado: (2021)

Payer Perspectives on Intravenous versus Subcutaneous Administration of Drugs
por: Epstein, Robert S
Publicado: (2021)

Osteochondral Allografting for Knee Lesions in the Pediatric and Adolescent Population
por: Pennock, Andrew T., et al.
Publicado: (2013)

Economic Evaluation of PCSK9 Inhibitors in Reducing Cardiovascular Risk from Health System and Private Payer Perspectives
por: Arrieta, Alejandro, et al.
Publicado: (2017)

The Social Contexts of Birthing People with Public- and Private-Payer Prenatal Care: Illuminating an Understudied Aspect of the Patient Experience
por: Garrett, Sarah B., et al.
Publicado: (2022)

Commercial and public payer opioid analgesic prescribing policies: a case study
por: Arfken, Cynthia L., et al.
Publicado: (2021)

Outcomes of Total Knee Arthroplasty After Osteochondral Allograft Transplantation
por: Steinhoff, Amy K., et al.
Publicado: (2014)

Osteochondral Allograft Transplantation of the Knee in “Ideal” Candidates: Clinical Outcomes and Graft Survivorship
por: Bugbee, William
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a5t949r4qktmttpmco3nltvsmf